STAA Staar Surgical
- 42.700
- +0.080+0.19%
- 42.360
- -0.340-0.80%
Staar Surgical News
Staar Surgical(STAA.US) 10% Shareholder Buys US$42.56 in Common Stock
$Staar Surgical(STAA.US)$ 10% Shareholder BROADWOOD PARTNERS, L.P. purchased 1 shares of common stock on May 9, 2024 at an average price of $42.56 for a total value of $42.56. This transaction involve
Returns At STAAR Surgical (NASDAQ:STAA) Appear To Be Weighed Down
To find a multi-bagger stock, what are the underlying trends we should look for in a business? Amongst other things, we'll want to see two things; firstly, a growing return on capital employed (ROCE)
STAAR Surgical First Quarter 2024 Earnings: Beats Expectations
Needham: Reiterates that Staar Surgical (STAA.US) holds the rating.
Needham: Reiterates that Staar Surgical (STAA.US) holds the rating.
Needham Reiterates Hold on Staar Surgical
Needham analyst David Saxon reiterates Staar Surgical (NASDAQ:STAA) with a Hold.
Why Upstart Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Upstart Holdings, Inc. (NASDAQ:UPST) fell sharply during Wednesday's session after the company reported first-quarter financial results and issued second-quarter revenue guidance below estim
Staar Surgical: A Hold Rating Amidst Conservative Guidance and Modest Growth Prospects
Staar Surgical Is Maintained at Hold by Canaccord Genuity
Staar Surgical Is Maintained at Hold by Canaccord Genuity
Staar Surgical Price Target Cut to $43.00/Share From $46.00 by Canaccord Genuity
Staar Surgical Price Target Cut to $43.00/Share From $46.00 by Canaccord Genuity
STAAR Surgical Shares Are Trading Lower After the Company Reported Q1 Financial Results.
STAAR Surgical Shares Are Trading Lower After the Company Reported Q1 Financial Results.
Canadian Investment Banking Group: Maintaining the Staar Surgical (STAA.US) rating, adjusted from holding to holding rating, and adjusted the target price from $46.00 to $43.00.
Canadian Investment Banking Group: Maintaining the Staar Surgical (STAA.US) rating, adjusted from holding to holding rating, and adjusted the target price from $46.00 to $43.00.
Canaccord Genuity Maintains Hold on Staar Surgical, Lowers Price Target to $43
Canaccord Genuity analyst Jon Young maintains Staar Surgical (NASDAQ:STAA) with a Hold and lowers the price target from $46 to $43.
Staar Surgical Price Target Raised to $40.00/Share From $33.00 by Piper Sandler
Staar Surgical Price Target Raised to $40.00/Share From $33.00 by Piper Sandler
Staar Surgical Is Maintained at Neutral by Piper Sandler
Staar Surgical Is Maintained at Neutral by Piper Sandler
Piper Sandler Maintains Neutral on Staar Surgical, Raises Price Target to $40
Piper Sandler analyst Matt O'Brien maintains Staar Surgical with a Neutral and raises the price target from $33 to $40.
Mizuho Adjusts STAAR Surgical's Price Target to $55 From $53, Keeps Buy Rating
STAAR Surgical (STAA) has an average rating of outperform and price targets ranging from $40 to $60, according to analysts polled by Capital IQ. Price: 42.16, Change: -4.49, Percent Change: -9.62
Earnings Call Summary | Staar Surgical(STAA.US) Q1 2024 Earnings Conference
The following is a summary of the STAAR Surgical Company (STAA) Q1 2024 Earnings Call Transcript:Financial Performance:STAAR Surgical posted Q1 2024 net sales of $77.4 million, exceeding estimates due
Staar Surgical Is Maintained at Buy by Mizuho
Staar Surgical Is Maintained at Buy by Mizuho
Staar Surgical Price Target Raised to $55.00/Share From $53.00 by Mizuho
Staar Surgical Price Target Raised to $55.00/Share From $53.00 by Mizuho
Mizuho Bank: Maintaining the Staar Surgical (STAA.US) rating, adjusted from buy to buy rating, and adjusted the target price from $53.00 to $55.00.
Mizuho Bank: Maintaining the Staar Surgical (STAA.US) rating, adjusted from buy to buy rating, and adjusted the target price from $53.00 to $55.00.
Analysis
Price Target
No Data
